LB0005 ORELABRUTINIB, AN IRREVERSIBLE INHIBITOR OF BRUTON'S TYROSINE KINASE (BTK), FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE IB/IIA DOSE-FINDING STUDY

R. Li, X. Zhu, S. Liu, X. Zhang, C. Xie, Z. Fu, Anaoxue Huang, L. Sun, D. Liu, Jingrun Zhao, Laifeng Wu, Z. Qin, S. Li, Y. Liu, Z. Li